Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1990 Nov;30(6):374–376. doi: 10.1007/BF01786888

Effects of opioid peptides on the cellular immunity in spleen cells from intact nude mice or nude mice bearing human ovarian carcinoma

Yoshihiro Kikuchi 1,, Tsunekazu Kita 1, Ichiro Nagata 1
PMCID: PMC11038896  PMID: 2302728

Abstract

The present study was designed to explore the effects of opioid peptides on the lytic activity of spleen cells from intact nude mice or nude mice bearing human ovarian cancer cells (KF). When the spleen cells from intact nude mice were incubated with various concentrations of opioid peptides, the ability of the spleen cells to lyse the KF cells was significantly stimulated between 0.05 nM and 50 nM concentrations of all opioid peptides used in this study. The degree of stimulation was most marked at 5 nM opioid peptides and the most marked stimulatory effect was obtained by α-endorphin. On the other hand, the lytic activity of spleen cells from nude mice challenged with the KF cells was about two-fold higher than that of intact nude mice, suggesting that spleen cells from nude mice challenged with KF cells have KF-cell-specific cytotoxicity. Even if the spleen cells were incubated with any concentration of α-endorphin or [Met]enkephalin indicated, the lytic activity remained unchanged. In contrast, only β-endorphin resulted in a significant increase of the lytic activity between 0.5 nM and 50 nM. These results suggest that opioid peptides play a crucial role in immune surveillance mechanisms.

Keywords: Peptide, Carcinoma, Cancer Cell, Ovarian Cancer, Nude Mouse

References

  • 1.Duka T, Höllt V, Przewlocki R, Wesche D. Distribution of methionine- and leucine-enkephalin within the rat pituitary gland measured by highly specific radioimmunoassays. Biochem Biophys Res Commun. 1978;85:1119. doi: 10.1016/0006-291x(78)90658-7. [DOI] [PubMed] [Google Scholar]
  • 2.Gilman SC, Schwartz JM, Milner RJ, Bloom FE, Feldman JD. β-Endorphin enhances lymphocyte proliferative responses. Proc Natl Acad Sci USA. 1982;79:4226. doi: 10.1073/pnas.79.13.4226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hazum E, Chang KJ, Cuatrecasas P. Specific nonopiate receptors for β-endorphins. Science. 1979;205:1033. doi: 10.1126/science.224457. [DOI] [PubMed] [Google Scholar]
  • 4.Kay N, Allen J, Morley JE. Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci. 1984;35:53. doi: 10.1016/0024-3205(84)90151-6. [DOI] [PubMed] [Google Scholar]
  • 5.Kikuchi Y, Hiramoto RN, Ghanta VK. Mitogen response of peripheral blood and specific lymphocytes and effect of 2-mercaptoethanol in tumor-bearing mice. Cancer Immunol Immunother. 1982;12:225. [Google Scholar]
  • 6.Kikuchi Y, Iwano I, Kato K. Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro. Biochem Biophyse Res Commun. 1984;123:385. doi: 10.1016/0006-291x(84)90425-x. [DOI] [PubMed] [Google Scholar]
  • 7.Kikuchi Y, Kita T, Miyauchi M, Iwano I, Kato K. Inhibition of human ovarian cancer cell proliferation in vitro by neuroendocrine hormones. Gynecol Oncol. 1989;32:60. doi: 10.1016/0090-8258(89)90851-2. [DOI] [PubMed] [Google Scholar]
  • 8.Matheus PM, Froelick CJ, Sibbitt WL, Jr, Bankhurst AD. Enhancement of natural cytotoxicity by β-endorphin. J Immunol. 1983;130:1658. [PubMed] [Google Scholar]
  • 9.Wybran J. Enkephalins and endorphins as modifiers of the immune system: present and future. Fed Proc. 1985;44:92. [PubMed] [Google Scholar]
  • 10.Wybran J, Appelboom T, Famaey JP, Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal and human blood T lymphocytes. J Immunol. 1979;123:1068. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES